Demoule, Alexandre
Fossé, Quentin
Mercat, Alain
Bergum, Daniel
Virolle, Sara
Bureau, Côme
Mellemseter, Marit
Guichou, Rafaël
Similowski, Thomas
Dres, Martin
Mortaza, Satar
Clinical trials referenced in this document:
Documents that mention this clinical trial
Operator independent continuous ultrasound monitoring of diaphragm excursion predicts successful weaning from mechanical ventilation: a prospective observational study
https://doi.org/10.1186/s13054-024-05003-0
Article History
Received: 27 March 2024
Accepted: 24 June 2024
First Online: 16 July 2024
Declarations
:
: The study protocols were approved by the local ethics committee in France (Comité de Protection des Personnes Sud-Est 1, n. 2018-13) and Norway (REK midt, n. 2018/941). Patients or next of kin gave written consent to participate.
: Not applicable.
: A Demoule received personal fees during the conduct of the study from RESPINOR; outside the submitted work, he reports grants from French Ministry of Health, RESPINOR, Lungpacer Assistance Publique – Hôpitaux de Paris, personal fees from Fisher & Paykel, RESPINOR, Lungpacer, Liberate Medical, Tribunal Administratif de Cergy, Philips, SAT Lutech, Astra, Mindray, outside the submitted work. M Mellemseter and R Guichou received salary support and stock options compensation as full-time employees of RESPINOR. T Similowski reports grants from Lungpacer, consulting fees from ADEP Assistance, AstraZeneca France, Chiesi France, KPL consulting, Lungpacer Inc, Novartis France, TEVA France, Vitalaire, outside the submitted work. M Dres reports personal fees and grants from Lungpacer unrelated to the work submitted. S Virolle, A Mercat, Q Fosse, D Bergum, C Bureau and S Mortaza have nothing to disclose.